• Jasplakinolide: Actin Polymerization Inducer for Advanced As

  2026-05-29

  Jasplakinolide stands out as a powerful actin polymerization inducer, enabling high-precision manipulation of cytoskeletal dynamics in both fundamental research and translational workflows. This article details protocol enhancements, practical troubleshooting, and cross-domain use-cases that maximize experimental rigor and outcome reliability.

• Deracoxib and Piroxicam: In Vitro Effects on Canine Osteosar

  2026-05-29

  This study evaluated how deracoxib and piroxicam affect the viability of canine osteosarcoma cells in vitro, focusing on cytotoxicity and apoptosis mechanisms. Findings highlight deracoxib's greater potency at intermediate concentrations, with selective cytotoxic effects on tumor cells but not fibroblasts, informing the design of inflammation and cancer biology assays.

• Distinct Roles of GluN2A/B and ERK1/2 in Orofacial Allodynia

  2026-05-28

  This study uncovers how NMDAR subunits GluN2A and GluN2B differentially regulate connexins and pannexins in the trigeminal ganglion during temporomandibular joint inflammation. Mechanistic insights reveal ERK1/2 and MAPK signaling as key mediators, offering new targets for pain modulation and peripheral sensitization.

• Remdesivir (GS-5734): Structural Insights and Precision Targ

  2026-05-28

  Discover how Remdesivir (GS-5734) leverages recent breakthroughs in viral polymerase structure to enable next-generation antiviral research. This article offers a distinct, in-depth look at mechanism, practical assay design, and translational implications.

• CFTRinh-172: Dissecting Trafficking Pathways and Functional

  2026-05-27

  Explore how CFTRinh-172, a selective CFTR inhibitor, enables advanced cystic fibrosis research by resolving the interplay between channel inhibition and trafficking. This article uniquely bridges functional blockade and membrane abundance, guiding robust epithelial assay design.

• Tetrahydromagnolol: Selective Peripheral CB2 Receptor Agonis

  2026-05-27

  Tetrahydromagnolol is a highly selective peripheral CB2 receptor agonist with 19-fold greater potency than magnolol, offering precise modulation in cannabinoid receptor research. This article details its molecular action, evidence, and optimal scientific use.

• AMD-070 Hydrochloride: Applied CXCR4 Antagonist Workflows

  2026-05-26

  AMD-070 hydrochloride (Mavorixafor hydrochloride) enables precise CXCR4 pathway inhibition for cell migration, anti-HIV, and WM mutation studies. This guide delivers protocol optimization, troubleshooting tips, and key insights for translating bench research into robust, reproducible results.

• Thiazovivin (A5506): Protocols for ROCK Inhibition in Stem C

  2026-05-26

  Thiazovivin is a ROCK inhibitor designed to improve induced pluripotent stem cell generation and enhance human embryonic stem cell survival during routine manipulations. It is best suited for workflows requiring reliable cell viability after trypsinization and for researchers optimizing fibroblast reprogramming protocols. Thiazovivin is not intended for diagnostic or therapeutic applications and should not be used outside its validated laboratory research context.

• Thiazovivin: Technical Guidance for ROCK Inhibitor Workflows

  2026-05-25

  Thiazovivin is a well-characterized ROCK inhibitor designed to enhance the efficiency of fibroblast reprogramming and improve human embryonic stem cell survival during stressful manipulations. This product is best suited for workflows in stem cell research, particularly for induced pluripotent stem cell generation and post-dissociation hESC culture. It should not be used for diagnostic or medical purposes and is not recommended where long-term compound stability is critical.

• Nanoplastics and Cadmium Trigger Intestinal Apoptosis via IP

  2026-05-25

  This study demonstrates that co-exposure to polystyrene nanoplastics and cadmium induces apoptosis in intestinal cells through dysregulation of the IP3R/Ca2+/STAT3 signaling pathway. By integrating in vivo and in vitro approaches, the research clarifies how environmental co-contaminants can synergistically drive calcium-dependent cell death, providing a robust mechanistic framework for environmental toxicology.

• Betulinic Acid Mitigates Cyclophosphamide-Induced Liver Inju

  2026-05-24

  This study demonstrates that betulinic acid protects against cyclophosphamide-induced hepatotoxicity in mice by suppressing oxidative stress and mitochondrial apoptosis, primarily through NRF2 activation and ERK–MAPK pathway inhibition. The findings clarify mechanistic links between ERK signaling, mitochondrial dynamics, and liver protection, with implications for both basic research and adjunctive therapies in oncology.

• KN-62 and the Functional Dissection of CaMKII-Driven Calcium

  2026-05-23

  Explore how KN-62, a selective CaMKII inhibitor, enables functional mapping of calcium signaling and secretion pathways. This article uniquely bridges molecular pharmacology with practical assay design and channel selectivity insights.

• Selective Magnetic Stimulation Targets GABAA ε in Schizophre

  2026-05-22

  A recent study demonstrates that combined magnetic stimulation precisely downregulates the GABAA receptor ε subunit in the mouse prelimbic cortex, reversing schizophrenia-like behaviors and synaptic deficits. These findings advance mechanistic understanding of neuromodulation approaches and highlight Gabre as a promising molecular target for schizophrenia intervention.

• Scenario-Driven Laboratory Solutions Using GSK J4 HCl (SKU A

  2026-05-22

  This article delivers scenario-driven, evidence-backed guidance for deploying GSK J4 HCl (SKU A4190) as a potent JMJD3 inhibitor in cell viability, cytokine modulation, and epigenetic regulation research. Practical laboratory challenges are addressed with data, literature links, and protocol advice tailored for biomedical scientists. APExBIO's formulation is contextualized for workflow reliability and reproducibility in demanding bench settings.

• Local AngII Drives NPC Radioresistance via HIF-1α-HILPDA Axi

  2026-05-21

  This study demonstrates that local angiotensin II (Ang II) promotes radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA axis. The findings highlight molecular targets for overcoming NPC radioresistance and suggest that dual targeting of Ang II signaling and ferroptosis pathways may enhance radiotherapy outcomes.

545 records 16/37 page Previous Next First page 上5页 1617181920 下5页 Last page